Home
    Disclaimer
    πŸ§ͺ This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    O-PCE

    Aliases: 2-dcnek, 2-oxo-pce, Eticyclidone, N-ethyldeschloroketamine, Deschloro-n-ethyl-ketamine, 2'-oxo-pce, opce

    Summary TheDrug.Wiki TripSit PsychonautWiki

    2'-Oxo-PCE (also known as as Eticyclidone, and O-PCE) is a lesser-known novel dissociative substance of the arylcyclohexylamine class that produces dissociative, anesthetic, stimulating and hallucinogenic effects when administered. It is structurally related to arylcyclohexylamines like MXE, 3-MeO-PCE, and deschloroketamine and is speculated to produce its effects through its activity as an NMDA receptor antagonist. The structural similarities O-PCE shares with DCK and ketamine which has been speculated to have antibacterial properties, has raised some concern as to whether it also shares these properties as well.

    Perspectives

    “This is a spooky substance. It is one of the blankest and most neutral feeling dissociatives I have ever taken. It robs me entirely of emotions, it is neither euphoric nor dysphoric just incredibly blank and grey.”

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Insufflated BA ~70% 3-6mg 6-12mg 12-20mg 20mg+
    Oral BA ~50% 3-5mg 5-15mg 15-25mg 25mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects Total
    Insufflated 1-4 min 4-15 min 1-2 hrs 1-2 hrs 2-12 hrs 4-6 hrs
    Oral 19-40 min 30-60 min 2-3 hrs 1-2 hrs 4-48 hrs -

    Effect Profile

    18 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Dissociative 5.1
    Moderate+ 5/10

    Strong dissociative depth, mania, and motor impairment with low insight

    Dissociative Depth ×3
    10
    depersonalization derealization physical disconnection visual disconnection physical autonomy perception of bodily lightness +3 more
    Mania / Compulsion ×1
    10
    mania compulsive redosing disinhibition stimulation
    Insight / Novel Thought ×2
    3
    conceptual thinking
    Motor / Sensory Impairment ×1
    10
    motor control loss physical disconnection tactile suppression numbness spatial disorientation visual disconnection

    Tolerance

    Build-up develops with repeated use over days to weeks
    Reset 2–4 weeks for noticeable reduction

    Tolerance Decay

    Full tolerance 1d Half tolerance 7d Baseline ~14d

    Rapid tolerance build and partial cross‑tolerance across arylcyclohexylamines are widely reported; values above are heuristic and based on anecdotal patterns. Space sessions 10–14 days when possible to reduce escalation risk.

    Cross-Tolerances

    ketamine
    60%
    MXE
    60%

    Effects Erowid

    Aggregated from 18 Erowid experience reports

    Positive Effects 11

    Euphoria 83.3% 70%
    Music Enhancement 77.8% 70%
    Stimulation 61.1% 70%
    Tactile Enhancement 50.0% 70%
    Focus Enhancement 44.4% 70%
    Color Enhancement 38.9% 70%
    Empathy 33.3% 70%
    Introspection 22.2% 70%
    Body High 22.2% 70%
    Pain Relief 22.2% 70%
    Creativity Enhancement 16.7% 70%

    Adverse Effects 8

    Motor Impairment 55.6% 70%
    Confusion 50.0% 70%
    Anxiety 38.9% 70%
    Muscle Tension 33.3% 70%
    Memory Suppression 22.2% 70%
    Nausea 22.2% 70%
    Sweating 22.2% 70%
    Increased Heart Rate 16.7% 70%

    Combinations TripSit

    Trip Reports Effect Index

    Helpful Links